Urinary biotransformation metabolic detoxication phase i. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Microsomes, Liver Urinary Bladder Liver Urinary Tract Urine Bile Kidney Feces Hepatocytes Microsomes

Organisms14

Cunninghamella Rats, Inbred F344 Rats, Sprague-Dawley Coxiella Gordonia Bacterium Oncorhynchus kisutch Berberidaceae Hepatophyta Dogs Mucorales Ictaluridae Rats, Wistar Rhodococcus Pseudomonas putida

Diseases14

Psychoses, Alcoholic Urinary Tract Infections Urinary Incontinence Urinary Calculi Neoplasms Urinary Retention Urinary Incontinence, Stress Urinary Bladder Neoplasms Urinary Bladder Diseases Nausea Urologic Diseases Neutropenia Urination Disorders Urinary Bladder Calculi

Chemicals and Drugs77

Bithionol Thymol Glutathione Transferase Cytochrome P-450 Enzyme System Cytochrome P-450 CYP1A1 Aflatoxin B1 Aristolochic Acids Carcinogens Adrenochrome Aminopyrine N-Demethylase Benzo(a)pyrene NAD(P)H Dehydrogenase (Quinone)Glutathione Cytochrome P-450 CYP1A2 DNA Adducts Carboxylesterase Glucosinolates Anticarcinogenic Agents Isoenzymes Thiocyanates Carboxylic Ester Hydrolases Isothiocyanates Cytochrome P-450 CYP3A Xenobiotics Pyrazines Ketoconazole Glucuronosyltransferase Aryl Hydrocarbon Hydroxylases Trichloroethanes Glucuronides Antineoplastic Agents Trinitrotoluene Mixed Function Oxygenases Glucuronates Oxygenases Oxidoreductases, N-Demethylating Environmental Pollutants Troleandomycin Prodrugs Equol Hydrocarbons, Halogenated Toluene Monoterpenes Methoxyflurane Cytochrome P-450 CYP2E1 Carbon Radioisotopes Arylamine N-Acetyltransferase Isoflavones Water Pollutants, Chemical Cytochrome P-450 CYP2D6 Triazines Nitroglycerin Recombinant Proteins Cytochrome P-450 CYP2B1 Fenthion Pharmaceutical Preparations Anti-Infective Agents, Urinary Antineoplastic Agents, Phytogenic Enzyme Inhibitors Ethylmorphine Arsenic Norisoprenoids Benzaldehydes Coumarins Phenols Pyrazolones Polycyclic Hydrocarbons, Aromatic Biological Markers Hydrocarbons, Aromatic Creatinine Ethyl Ethers 7-Alkoxycoumarin O-Dealkylase Soil Pollutants Hydrocarbons, Chlorinated Atrazine Ethylmercuric Chloride Eugenol

Analytical, Diagnostic and Therapeutic Techniques and Equipment22

Clinical Trials, Phase I as Topic Chromatography, High Pressure Liquid Maximum Tolerated Dose Urinary Catheterization Mass Spectrometry Drug Evaluation Drug Administration Schedule Administration, Oral Gas Chromatography-Mass Spectrometry Area Under Curve Infusions, Intravenous Magnetic Resonance Spectroscopy Metabolic Clearance Rate Treatment Outcome Chromatography, Liquid Urinary Diversion Antineoplastic Combined Chemotherapy Protocols Tandem Mass Spectrometry Spectrometry, Mass, Electrospray Ionization Urinalysis Injections, Intravenous Spectrophotometry, Ultraviolet

Psychiatry and Psychology1

Psychoses, Alcoholic

Phenomena and Processes24

Metabolic Detoxication, Drug Biotransformation Metabolic Detoxication, Phase I Metabolic Detoxication, Phase II DNA Adducts Oxidation-Reduction Enzyme Induction Dose-Response Relationship, Drug Dealkylation Hydroxylation Maximum Tolerated Dose Kinetics Substrate Specificity Half-Life Area Under Curve Stereoisomerism Molecular Structure Metabolic Clearance Rate Species Specificity Drug Interactions Time Factors Tissue Distribution Biological Availability Urodynamics

Information Science1

Molecular Sequence Data

Health Care4

Clinical Trials, Phase I as Topic Biodegradation, Environmental Area Under Curve Treatment Outcome

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Health Care

Bithionol Thymol Metabolic Detoxication, Drug Biotransformation Metabolic Detoxication, Phase I Metabolic Detoxication, Phase II Glutathione Transferase Clinical Trials, Phase I as Topic Cytochrome P-450 Enzyme System Microsomes, Liver Cytochrome P-450 CYP1A1 Psychoses, Alcoholic Aflatoxin B1 Cunninghamella Chromatography, High Pressure Liquid Urinary Bladder Aristolochic Acids Carcinogens Adrenochrome Liver Urinary Tract Infections Aminopyrine N-Demethylase Benzo(a)pyrene NAD(P)H Dehydrogenase (Quinone)Glutathione Cytochrome P-450 CYP1A2 DNA Adducts Urinary Tract Carboxylesterase Glucosinolates Anticarcinogenic Agents Oxidation-Reduction Enzyme Induction Urinary Incontinence Isoenzymes Dose-Response Relationship, Drug Dealkylation Thiocyanates Hydroxylation Carboxylic Ester Hydrolases Maximum Tolerated Dose Isothiocyanates Rats, Inbred F344 Cytochrome P-450 CYP3A Xenobiotics Pyrazines Urinary Calculi Ketoconazole Kinetics Neoplasms Biodegradation, Environmental Urinary Catheterization Substrate Specificity Urinary Retention Mass Spectrometry Glucuronosyltransferase Drug Evaluation Aryl Hydrocarbon Hydroxylases Drug Administration Schedule Administration, Oral Rats, Sprague-Dawley Gas Chromatography-Mass Spectrometry Trichloroethanes Glucuronides Antineoplastic Agents Half-Life Area Under Curve Trinitrotoluene Stereoisomerism Molecular Structure Urinary Incontinence, Stress Infusions, Intravenous Urinary Bladder Neoplasms Mixed Function Oxygenases Urinary Bladder Diseases Magnetic Resonance Spectroscopy Glucuronates Oxygenases Coxiella Gordonia Bacterium Metabolic Clearance Rate Urine Molecular Sequence Data Bile Treatment Outcome Chromatography, Liquid Urinary Diversion Oxidoreductases, N-Demethylating Kidney Antineoplastic Combined Chemotherapy Protocols Feces Environmental Pollutants Species Specificity Troleandomycin Drug Interactions Prodrugs Time Factors Equol Oncorhynchus kisutch Tandem Mass Spectrometry

No FAQ available that match "urinary biotransformation metabolic detoxication phase i"